SEC Form 4 · accession 0001209191-17-013801
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Campanelli
Officer — President, CEO · Director
Period of report
Feb 21, 2017
Accepted (ET)
Feb 23, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Incentive Plan Restricted Stock Units (RSU)F1,F2 | Feb 21, 2017 | A | 227,445 | — | A | 250,792 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 Stock Incentive Plan Stock Options (NQ)F3,F2,F4 | $13.19 | Feb 21, 2017 | A | 510,204 | A | — | Feb 21, 2027 | Ordinary Shares | 510,204 | 510,204 | D |
Explanation of responses
- F1Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 33 1/3% per year on each of February 21, 2018, February 21, 2019 and February 21, 2020. Upon vesting, we consider the underlying RSUs to be expired.
- F2These securities were granted to Mr. Campanelli in consideration of his services as President and Chief Executive Officer of Endo International plc.
- F3Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc.
- F4These stock options are generally exercisable 25% per year on each of February 21, 2018, February 21, 2019, February 21, 2020 and February 21, 2021.